FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Whitcup Scott M   2. Issuer Name and Ticker or Trading Symbol ALLERGAN INC [AGN] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Executive VP, R&D, CSO (Last) (First) (Middle) 2525 DUPONT DRIVE 3. Date of Earliest Transaction (Month/Day/Year) 03/17/2015 (Street) IRVINE, CA 92612 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 02/20/2015   G V 9,766 D $ 0 7,409 D   Common Stock 03/17/2015   A   11,273.669 (1) A $ 0 18,682.669 D   Common Stock 03/17/2015   D   18,682.669 (2) D (2) 0 D   Common Stock 03/17/2015   D   1,739.1061 (2) D (2) 0 I By Esop Common Stock 03/17/2015   D   1,709.7067 (2) D (2) 0 I By 401(k)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$ 58.55	03/17/2015		D			89,200 (3)	(4)	02/02/2017	Common Stock	89,200	(4)	0	D
Employee Stock Option (Right to Buy)	$ 64.47	03/17/2015		D			105,500	(4)	02/14/2018	Common Stock	105,500	(4)	0	D
Employee Stock Option (Right to Buy)	$ 40.16	03/17/2015		D			130,400	(4)	02/20/2019	Common Stock	130,400	(4)	0	D
Employee Stock Option (Right to Buy)	$ 59.13	03/17/2015		D			92,600	(4)	02/22/2020	Common Stock	92,600	(4)	0	D
Employee Stock Option (Right to Buy)	$ 75.58	03/17/2015		D			120,000	(4)	02/17/2021	Common Stock	120,000	(4)	0	D
Employee Stock Option (Right to Buy)	$ 105.87	03/17/2015		D			60,000	(4)	02/21/2023	Common Stock	60,000	(4)	0	D
Employee Stock Option (Right to Buy)	$ 87.91	03/17/2015		D			25,000	(4)	02/17/2022	Common Stock	25,000	(4)	0	D
Employee Stock Option (Right to Buy)	$ 87.91	03/17/2015		D			67,000	(4)	02/17/2022	Common Stock	67,000	(4)	0	D
Employee Stock Option (Right to Buy)	$ 125.07	03/17/2015		D			58,815	(4)	02/21/2024	Common Stock	58,815	(4)	0	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Whitcup Scott M 2525 DUPONT DRIVE IRVINE, CA 92612			Executive VP, R&D, CSO

Signatures

/s/ Matthew J. Maletta, attorney-in-fact for Scott M. Whitcup		03/19/2015
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Represents 11,271 performance-based restricted stock units granted on October 29, 2014 and 2.6690 dividend equivalent rights acquired with respect to each vested restricted stock unit (collectively, the "RSUs"). The RSUs vested in full on the Effective Date pursuant to the terms of the Merger Agreement (each as defined below).
(2)	Pursuant to that certain Agreement and Plan of Merger dated November 16, 2014, (the "Merger Agreement") by and among the Issuer, Actavis, Plc ("Actavis) and a wholly-owned subsidiary of Actavis, the Issuer became an indirect wholly-owned subsidiary of Actavis upon consummation of the merger (the "Effective Date"). Each share of common stock was disposed of in exchange for $129.22 cash plus 0.3683 of an Actavis ordinary share, having a market value of $307.51 per share on the Effective Date.
(3)	The option was previously reported as covering 44,600 shares at an exercise price of $117.10. The Issuer effected a two-for-one stock split on June 22, 2007, which resulted in 89,200 shares held by the reporting person at an exercise price of $58.55.
(4)	Each option vested in full on the Effective Date and was cancelled in exchange for a cash payment equal to the number of shares subject to the option immediately prior to the merger, multiplied by the difference between (i) 0.3683 times $294.1509 (which represents the 10-day volume weighted average price of Actavis stock starting on the 11th trading day prior to the closing) plus $129.22 and (ii) the exercise price of the option, subject to the applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.